Anthony Lowe

Dr Anthony Lowe
Dr Anthony Lowe
Anthony Lowe in 2012
Born (1962-03-16) 16 March 1962
Mtarfa, Malta
Residence Sydney
Nationality British, Australian
Alma mater University of Cambridge (BA, MA, MMath), University of Southampton (PhD)
Known for Expertise in prostate cancer and PSA testing
Spouse(s) Sarah Lowe
Scientific career
Fields Prostate cancer, cancer control
Institutions Prostate Cancer Foundation of Australia, Menzies Health Institute Queensland, Griffith University
Doctoral advisor Tony Hey

Associate Professor Anthony Peter Lowe (born 16 March 1962) is a British-Australian mathematical physicist and actuary. He is a former Chief Executive Officer at Prostate Cancer Foundation of Australia[1] and a frequent media commentator on prostate cancer and prostate specific antigen (PSA) testing.[2][3][4][5][6][7][8][9][10][11][12]

His current research interests are community attitudes towards prostate cancer and cancer survivorship, particularly the psychosocial and economic aspects of survivorship.

Life and career

Dr Lowe was born in Malta and educated at The Perse School Cambridge. He studied mathematics at the University of Cambridge, graduating in 1983 and completing his Master of Mathematics (Part III of the Mathematical Tripos) in 1984. He was elected a Scholar of Robinson College, Cambridge in July 1983.

In 1984 Dr Lowe moved to the University of Southampton where he completed his Doctor of Philosophy in theoretical physics.[13]

After completing his PhD Dr Lowe joined consulting actuaries R Watson & Sons (now part of Willis Towers Watson) and trained as an actuary. He was made a Fellow of the Institute of Actuaries in 1990 and was appointed a Partner of R Watson & Sons in 1991.

In 1994 Dr Lowe moved to Sydney, Australia. Shortly after moving to Sydney he joined AMP Limited’s superannuation consulting business as Investment Consulting Practice Leader. Whilst at AMP Dr Lowe led an AusAID funded project advising the Kingdom of Tonga on reform of their Civil Service Pension Scheme. He was subsequently appointed Program Director of a business change program in partnership with Andersen Consulting (now Accenture) to reengineer AMP's corporate superannuation administration platform (people, processes and technology).

In 1998 Dr Lowe joined Mercer where he held a variety of senior executive roles. He was appointed a Worldwide Partner in 1998 and Executive Director of Mercer's Australian business in 2001. From 2002 to 2004 Dr Lowe was seconded to Mercer’s US business as US Benefits Administration Practice Leader based in Princeton, New Jersey. Dr Lowe’s ultimate role at Mercer was Asia-Pacific Business Group Leader, Mercer Wealth Solutions with responsibility for Mercer's benefits administration businesses in Australia, New Zealand and Hong Kong, including the Mercer Super Trust and Mercer Portfolio Service.[14]

In 1999 Dr Lowe was made a Fellow of the Institute of Actuaries of Australia (Actuaries Institute). He was a member of Actuaries Institute's Leadership & Career Development Committee from 2011 to 2018 and has been a member of the Institute's Public Policy Council Committee since 2014.

In 2007 Dr Lowe decided to move to the non-profit sector and was appointed Chief Operating Officer at the National Breast Cancer Foundation.[15] Whilst at the National Breast Cancer Foundation he led the design and implementation of the integrated website and customer relationship management systems for the Pink Ribbon Breakfast campaign[16] and Register4,[17][18] Australia's first online community for volunteer breast cancer research participants.

From 2011 to 2018 Dr Lowe was Chief Executive Officer at Prostate Cancer Foundation of Australia (PCFA).[19] In this role he pursued an agenda of ensuring its activities and programs are based on the latest available scientific and medical evidence. Under his leadership, PCFA established its Prostate Cancer Specialist Nursing Service which he worked to grow to 45 nurses nationally over a five-year period.

Dr Lowe has championed prostate cancer survivorship research in partnership with Professor Suzanne Chambers of Griffith University, particularly the development of ProsCare, a psychological care model for men with prostate cancer, and research into the financial implications of treatment for prostate cancer.[20] In 2012 he was appointed Adjunct Associate Professor at Menzies Health Institute Queensland, Griffith University. From 2012 to 2018 he was co-lead with Professor Chambers of the National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Prostate Cancer Survivorship.[21] Dr Lowe has also championed the development of resources and peer support groups to meet the particular needs of gay and bisexual men[22][23] and men from culturally and linguistically diverse[24] and Aboriginal and Torres Strait Islander[25] communities with prostate cancer.

Dr Lowe was project convenor, co-convenor with Professor Ian Olver, and a member of the Expert Advisory Panel for the development of national clinical practice guidelines on PSA testing and early management of test-detected prostate cancer.[26] The guidelines were auspiced by Cancer Council Australia and PCFA with the aim of building consensus around PSA testing and bringing order to Australia’s de facto unorganised prostate cancer screening program.[27] The guideline recommendations were approved by the Chief Executive Officer of NHMRC on 2 November 2015 and were published on 20 January 2016.[28][29][30]

Dr Lowe has been a member of ANZUP Cancer Trials Group[31] since 2012. From 2015 to 2018 he worked to secure funding for ANZUP's Australian-first clinical trial of 177Lu-PSMA treatment for prostate cancer. The trial opened for recruitment in February 2018.

In 2016 Dr Lowe was appointed Non-Executive Director and Company Secretary of Ensemble Offspring[32], Australia's pre-eminent new music group dedicated to the performance of innovative new music.

Dr Lowe is the nephew of biologist and ichthyologist Rosemary Lowe-McConnell.

Selected Publications

  • Research, Awareness, Support: Ten Years of Progress in Prostate Cancer[33]
  • New Therapies for Advanced Cancers: Can Our Society Afford Them? Is it Ethical to Deny Patients Access to Them?[34]
  • Prostate Cancer: The Next Generation[35]
  • Prostate Cancer Information Needs of Australian Gay and Bisexual Men[36]
  • ProsCare: A Psychological Care Model for Men with Prostate Cancer[37]
  • Culturally and Linguistically Diverse Communities and Prostate Cancer[38]
  • Financial Toxicity: A Potential Side Effect of Prostate Cancer Treatment Among Australian Men[39]
  • Advancing Prostate Cancer Survivorship Research in Australia[40]
  • Clinical Practice Guidelines for PSA Testing and Early Management of Test-Detected Prostate Cancer[41]
  • Advocacy, Support and Survivorship in Prostate Cancer[42]
  • Private Health Insurance Bill Shock: What Can Insurers Do to Help?[43]
  • Estimating the Healthcare Costs of Treating Prostate Cancer in Australia: A Markov Modelling Analysis[44]

Fellowships

  • Fellow of the Institute of Actuaries
  • Fellow of the Institute of Actuaries of Australia

Awards

References

  1. ↑ Annual Report 2011–2012. Prostate Cancer Foundation of Australia 2012
  2. ↑ Jill Margo. Blue is the New Pink. Australian Financial Review 4 August 2011 "Archived copy". Archived from the original on 2014-03-13. Retrieved 2014-03-13.
  3. ↑ Julia Rowbotham. Men urged to persist with disputed prostate test. Sydney Morning Herald 8 October 2011.
  4. ↑ Interview with Dr John D'Arcy. Prostate Cancer – surgery is not always the answer. 5 August 2012
  5. ↑ Anthony Lowe. Getting to the Bottom of the Great PSA Controversy. The Punch 26 November 2012.
  6. ↑ Ron Hughes. Talking about prostate cancer. Gay News Network 18 April 2013 "Archived copy". Archived from the original on 2014-03-13. Retrieved 2014-03-13.
  7. ↑ Interview with Tony Eastley and Tom Nightingale. More prostate cancers, but survival rates increasing. AM 14 November 2013
  8. ↑ Jill Margo. The Prostate Cancer Conundrum. Australian Financial Review 15 November 2013
  9. ↑ Men die earlier but women's health gets four times more funding. news.com.au 4 January 2014
  10. ↑ Public Seminar on Prostate Cancer - A/Prof Anthony Lowe and A/Prof Ganesh Raj. Freemasons Centre for Men's Health, The University of Adelaide 17 February 2014
  11. ↑ Jill Margo. Prostate choice clearer. Australian Financial Review 5 March 2014
  12. ↑ Jane Cadzow. Cancer Wars. Sydney Morning Herald 8 March 2014
  13. ↑ Lowe, A. Lattice Gauge-Higgs Theories (PhD Thesis). University of Southampton 1987
  14. ↑ Barrie Dunstan. Super trust goes shopping. Australian Financial Review 8 February 2005
  15. ↑ Candice Sng. Rebel with a Cause. Actuaries Magazine. Actuaries Institute August 2012
  16. ↑ Beverley Head. Pink Ribbon connections all tied up. Sydney Morning Herald 9 September 2008
  17. ↑ Chloe Herrick. Breast Cancer Foundation deploys CRM for Register4 initiative. Computerworld 3 November 2010
  18. ↑ register4.org.au
  19. ↑ Media Release PCFA appoints new CEO - Dr Anthony Lowe. Prostate Cancer Foundation of Australia 28 March 2011
  20. ↑ Gordon LG, Reinking S, Mervin C. The Financial Impact of Prostate Cancer in Australia. Final Report August 2013. Centre for Applied Health Economics, Griffith Health Institute, Griffith University. Meadowbrook Queensland.
  21. ↑ www.prostatecancersurvivorship.org.au
  22. ↑ Jill Margo. Putting prostate problems in non-heterosexual men on the agenda. Australian Financial Review 3 July 2013
  23. ↑ New resources for gay and bisexual men to fill gap in prostate cancer support. Star Online 13 August 2014
  24. ↑ Jill Margo. Ethnic communities vague on prostate risks. Australian Financial Review 10 September 2014
  25. ↑ Culturally-Specific Prostate Cancer Resource Launched. Coast Community News 15 December 2015
  26. ↑ PSA Testing and Early Management of Test-Detected Prostate Cancer: Clinical Practice Guidelines
  27. ↑ Annual Report 2012–2013. Prostate Cancer Foundation of Australia 2013
  28. ↑ Jill Margo. Doctors call for end to digital prostate check. Australian Financial Review 4 December 2014
  29. ↑ Jill Margo. Relief as prostate-testing consensus reached. Australian Financial Review 20 January 2016
  30. ↑ Jill Margo. Prostate testing breakthrough after 20 yrs of confusion. Australian Financial Review 20 January 2016
  31. ↑ www.anzup.org.au
  32. ↑ www.ensembleoffspring.com
  33. ↑ Lowe, A., Bennett, M., Badenoch, S. Research, Awareness, Support: Ten Years of Progress in Prostate Cancer. Prostate Cancer Foundation of Australia 2012. ISBN 978-0-646-58388-4
  34. ↑ Lowe, A., Dyson, S. New Therapies for Advanced Cancers: Can Our Society Afford Them? Is it Ethical to Deny Patients Access to Them? Actuaries Institute 2013
  35. ↑ Lowe, A., Wong, W., Lowe, S. Prostate Cancer: The Next Generation. Prostate Cancer Foundation of Australia 2013 ISBN 978-0-646-90677-5
  36. ↑ Wong, W., Lowe, A., Dowsett, G., Duncan, D., O'Keeffe, D. Mitchell, M. Prostate Cancer Information Needs of Australian Gay and Bisexual Men. Prostate Cancer Foundation of Australia 2013. ISBN 978-0-9923335-8-4
  37. ↑ Chambers, S., Dunn, J., Lazenby, M., Clutton, S., Newton, U., Cormie, P., Lowe, A., Sandoe, D., Gardiner, R. ProsCare: A Psychological Care Model for Men with Prostate Cancer. Prostate Cancer Foundation of Australia 2013. ISBN 9780-9923508-3-3
  38. ↑ Wong, W., Lowe, S., Lowe, A. Culturally and Linguistically Diverse Communities and Prostate Cancer. Prostate Cancer Foundation of Australia 2014 ISBN 978-0-9923508-9-5
  39. ↑ Gordon, L.G., Walker, S.M., Mervin, M.C., Lowe, A., Smith, D. P., Gardiner, R. A., Chambers, S. K. Financial Toxicity: A Potential Side Effect of Prostate Cancer Treatment Among Australian Men. European Journal of Cancer Care 2015
  40. ↑ Suzanne K Chambers, Paul A Scuffham, Peter D Baade, Anthony P Lowe, Jeff Dunn, Daniel A Galvão, Louisa Gordon, David P Smith, David F Sandoe, Addie C Wootten, Nigel A Spry, Robert A Gardiner, Ian D Davis, Robert U Newton. Advancing Prostate Cancer Survivorship Research in Australia. CancerForum, Nov 2015, Volume 39, Number 3, 204-209
  41. ↑ Prostate Cancer Foundation of Australia and Cancer Council Australia PSA Testing Guidelines Expert Advisory Panel. Clinical practice guidelines for PSA testing and early management of test-detected prostate cancer. Prostate Cancer Foundation of Australia and Cancer Council Australia, Sydney (2016)
  42. ↑ Dunn J. Casey C., Sandoe D., Hyde M.K., Cheron-Sauer M-C., Lowe A., Oliffe J.L, Chambers S. K. (2017) European Journal of Cancer Care. Advocacy, Support and Survivorship in Prostate Cancer
  43. ↑ Lowe A., Reid J. Private Health Insurance Bill Shock: What Can Insurers Do to Help? The Dialogue. Actuaries Institute June 2017
  44. ↑ 25. Gordon L. G., Tuffaha, H., James R., Keller, A. T., Lowe, A., Scuffham, P. A., Gardiner R. A., Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis. Urologic Oncology. 2017. doi: 10.1016/j.urolonc.2017.10.024
  45. ↑ Actuaries Magazine. Actuaries Institute. November 2013
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.